GW
Goldenwell Biotech, Inc.
GWLL · OTC
$0.69 +0.00% (+$0.00)
Market Cap $68.3M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 2,943.75x
P/E N/A
P/FFO N/A
Growth
0 /100
Declining Rev. growth 79.43%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 107.83%
FCF margin 111.64%
Net margin 1,130.45%
Quality
69 /100
Excellent ROIC 144.34%
Asset turnover 0.64x
ROA 725.93%
Debt
42 /100
Moderate Current ratio 1.98x
Int. coverage -60.43x
Debt/Equity N/A
Stability
1 /100
Unstable Beta 4.60x
Profitable years 0
Rev. volatility 169.71%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GWLL
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Shuang Liu
Employees
3
Headquarters
Solon